Amundi’s MacroGenics MGNX Stock Holding History

Amundi’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$837K	Sell	181,245 -33,033	-15%	-$125K	﹤0.01%	1450
2026 Q1	$619K	Hold	214,278	–	–	﹤0.01%	1467
2025 Q4	$345K	Buy	+214,278	New	+$337K	﹤0.01%	1609
2025 Q3	–	Sell	-214,278	Closed	-$296K	–	1648
2025 Q2	$296K	Hold	214,278	–	–	﹤0.01%	1518
2025 Q1	$246K	Buy	+214,278	New	+$560K	﹤0.01%	1641

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Amundi's MGNX Position: Q2 2026 in Review

Amundi reduced its MacroGenics (MGNX) stake by 15% in Q2 2026, selling an estimated $125K and leaving 181,245 shares worth $837K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Amundi first reported a position in MGNX in Q1 2025 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Amundi held 181,245 shares of MacroGenics worth $837K as of Q2 2026.
Amundi sold 33,033 MacroGenics shares in Q2 2026, an estimated $125K.
MacroGenics made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1450 holding.
Amundi first reported a position in MacroGenics in Q1 2025 and has held it in 5 quarters since.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.